Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-05-02
2006-05-02
Kunz, Gary (Department: 1647)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S070100, C435S320100, C435S252300, C435S254110, C536S023100, C536S023500
Reexamination Certificate
active
07037677
ABSTRACT:
The present invention relates to novel cytoplasmic tyrosine kinases isolated from megakaryoctyes (megakaryocyte kinases or MKKs) which are involved in cellular signal transduction pathways and to the use of these novel proteins in the diagnosis and treatment of disease. The present invention further relates to specific megakaryocyte kinases, designated MKK1, MKK2, and MKK3, and their use as diagnostic and therapeutic agents.
REFERENCES:
patent: 5635177 (1997-06-01), Bennett
patent: 5834208 (1998-11-01), Sakano
patent: WO 93/15201 (1993-08-01), None
Sambrook et al. (1989), Molecular Cloning: A Laboratory Manual, pp 11.45-11.57, Chapter 16 and 17.
Ngo et al., 1994, Computational Complexity, Protein Structure prediction, and the Levinthal Paradox, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Wells, Aditivity of Mutational Effects in Proteins, 1990, Biochemistry, vol. 26, No. 37, pp. 8509-8517.
Aaronson, Nov. 22, 1991, “Growth Factors and Cancer”,Science,254: 1146-1153.
Arpala et al., Mar. 1, 1994, “Defective T Cell Receptor Signaling and CD8+Thymic Selection in Humans Lacking Zap-70 Kinase,”Cell,76:947-958.
Bearman et al., Jan. 1979, “Acute (“Malignant”) Myelosclerosis,”Cancer,43(1):279-293.
Bennett et al., Jan. 14, 1994, “Identification and Characterization of a Novel Tyrosine Kinase from Megakaryocytes,”J. of Biol. Chem.,269(2):1068-1074.
Bolen, 1993, “Nonreceptor tyrosine protein kinases,”Oncogene,8:2025-2031.
Brauninger et al., Dec. 22, 1993, “Characterization of the human CSK locus,”Ontogene,8:1365-1369.
Brauninger et al., 1992, “Isolation and characterization of a human gene that encodes a new subclass of protein tyrosine kinases,”Gene,110:205-211.
Butler et al., Jun. 15, 1992, “Idiopathic Acquired Sideroblastic Anemia Terminating in Acute Myelosclerosis,”Cancer,49(12):2497-2499.
Cance et al., 1994,Cell Growth and Diff.,5:1347-1355.
Cance et al, 1993, “Novel Protein Kinases Expressed in Human Breast Cancer,”International Journal of Cancer,54(4):571-577.
Devereux et al., 1984, “A comprehensive set of sequence analysis programs for the VAX,”Nucleic Acids Research,12(1):387-395.
Eiseman et al., Oct. 1990, “src-Related Tyrosine Protein Kinases as Signalling Components in Hematopoietic Cells,”Cancer Cells,2(10):303-310.
Fohlmeister et al., 1986, “Acute Megakaryocyctic Myelosis Preceded by Myelodysplasia. Report of a Case and Review of the Literature,”VNU Science Press, Utrecht Akademiai Kiado,2:151-160.
Hardie, 1990, “Roles of Protein Kinases and Phosphatases in Signal Transduction,”Society for Experimental Biology,pp. 241-255.
Heldin & Westermark, Jul. 1990, “Platelet-derived growth factor: mechanism of action and possible in vivo function,”Cell Regulation,1:555-566.
Heyeck et al., Jan. 1993, “Development regulation of a murine T-cell-specific tyrosine kinase gene, Tsk,”PNAS USA,90:669-673.
Hamaguchi et al., 1994, “Characterization of mouse non-receptor tyrosine kinase gene, HYL,”Oncogene,9:3371-3374, Macmillan Press Ltd.
Hiraj et al., Dec. 18, 1987, “A Novel Putative Tyrosine Kinase Receptor Encoded by the eph Gene,”Science,238:1717-1720.
Hoffman, Sep. 1989, “Regulation of Megakaryocytopoiesis,”Blood,74(4):1196-1212.
Huang et al., Oct. 5, 1990, “The Hematopoietic Growth Factor KL is Encoded by SI Locus and Is the Ligand of the c-kit Receptor, the Gene Product of W Locus,”Cell,63:225-233.
Ishida et al., 1993, “Biological and Biochemical Characteristics of Murine Megakaryoblastic Cell Line L8057,”Exp. Hematol.,21:289-298.
Kawakami et al., Dec. 1986, “Isolation and Oncogenic Potential of a Novel Human src-Like Gene,”Molecular and Cellular Biology,6(12):4195-4201.
Kipreos et al., Apr. 13, 1990, “Differential Phosphorylation of c-Abl in Cell Cycle Determined by cdc2 Kinase and Phosphatase Activity,”Science248:217-220.
Koch et al., May 3, 1991, “SH2 and SH3 Domains: Elements That Control Interactions of Cytoplasmic Signaling Proteins,”Science,252:668-674.
Lee et al., 1994, “Cloning of FRK, a novel human intracellular SRC-like tyrosine kinase-encoding gene,”Gene,138:247-251.
Lichter et al., 1988, “Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression by bridization using recombinant DNA libraries,”Hum. Genet.,80:224-234.
Long, 1993, “Population Heterogeneity Among Cells of the Megakaryocyte Lineage,”Stem Cells,11:33-40.
Lu et al., 1993, “Review of the Cytogenetic Changes in Acute Megakaryoblastic Leukemia: One Disease or Several?”Cancer Genet. Cytogenet.,67:81-89.
Maness, 1992, “Nonreceptor Protein Tyrosine Kinases Associated with Neuronal Development,”Dev. Neurosci.,14:257-270.
Mano et al., 1993, “Expression of a novel form of Tec kinase in hematopoietic cells and mapping of the gene to chromosome 5 neat Kit,”Oncogene,8:417-424.
Marino, Oct. 1989, “Acute myelofibrosis: Report of a cse and review of current literature,”JAOA,89(10):1323-1329.
Mayer et al., Mar. 1998, “A novel viral oncogene with structural similarity to phospholipase C,”Nature,332:272-275.
Moody et al., 1989, “Florid radiological appearance of megakaryoblastic leukaemia—an aid to earlier diagnosis,”Pediatric Radiology,19:486-488.
Morgan et al., Jun. 2, 1989, “Mitosis-Specific Phosphorylation of p60c-srcby p34cdc2-Associated Protein Kinase,”Cell,57:775-786.
Morgenstern & Land, 1990, “Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line”,Nucl. Acids Res.,18(12):3587-3596.
Muller et al., 1992, “BCR First Exon Sequences Specifically Activate the BCR/ABL Tyrosine Kinase Oncogene of Philadelphia Chromosome-Positive Human Leukemias,”Mol. Cell. Bio.,11:1785-1792.
Musacchio et al., Sep. 1993, “The PH domain: a common piece in the structural patchwork of signalling proteins,”TIBS18:343-348.
Mustelin & Burn, 1993, “Regulation of the src family tyrosine kinases in lymphocytes,”TIBS,18:215-220.
Pawson et al., Oct. 30, 1992, “SH2 and SH3 Domains: From Structure to Function,”Cell,71:359-362.
Pear et al., Sep. 1993, “Production of high-titer helper-free retroviruses by transient transfection,”Proc. Natl. Acad. Sci. USA,90:8392-8396.
Posada et al., Jun. 1992, “Molecular Signal Integration, Interplay Between Serine, Threonine, and Tyrosine Phosphorylation,”Mol. Biol. of the Cell,3:583-592.
Rawlings et al., Jul. 16, 1993, “Mutation of Unique Region of Bruton's Tyrosine Kinase in Immunodeficient XID Mice,”Science,261:358-361.
Sadowski et al., Dec. 1986, “A Noncatalytic Domain Conserved among Cytoplasmic Protein-Tyrosine Kinases Modifies the Kinase Function and Transforming of Fujinami Sarcoma Virus P130gag-fps,”Molecular and Cellular Biology,6(12), 4396-4408.
Sakano et al., 1994, “Molecular cloning of a novel non-receptor tyrosine kinase, HYL (hematopoietic) consensus tyrosine-lacking kinase,”Oncogene,9:1155-1161.
Sambrook et al., 1989,Molecular Cloning, A Lab Manual, Second Edition,Cold Spring Harbor Lab Press, 3:16.2-16.30, 17:1-17.28.
Schlessinger, Nov. 1988, “Signal transduction by allosteric receptor oligomerization,”TIBS,13:443-447.
Sherr et al., Jul. 1985, “The c-fms Prot-oncogene Product is Related to the Receptor for the Mononuclear Phagocyte Growth Factor, CSF-1,”Cell,41:665-676.
Smith et al., 1990, “Myelofibrosis: A Review of Clinical and Pathologic Features and Treatment,”Oncology/Hematology,10(4):305-314.
Soriano et al., Feb. 22, 1991, “Targeted Disruption of the c-src Proto-
Gishizky Mikhail
Sures Irmingard
Ullrich Axel
Burrous Beth A.
Foley & Lardner LLP
Kunz Gary
Max-Planck-Gessellschaft zur Forderung der Wissenschaften E.V.
Seharaseyon Jegatheesan
LandOfFree
Megakaryocytic protein tyrosine kinase I does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Megakaryocytic protein tyrosine kinase I, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Megakaryocytic protein tyrosine kinase I will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3542732